Literature DB >> 23359502

IL-2 produced by CD8+ immune T cells can augment their IFN-γ production independently from their proliferation in the secondary response to an intracellular pathogen.

Qila Sa1, Jerold Woodward, Yasuhiro Suzuki.   

Abstract

Chronic infection with Toxoplasma gondii induces a potent resistance against reinfection, and IFN-γ production by CD8(+) T cells is crucial for the protective immunity. However, the molecular mechanisms that regulate the secondary response remain to be elucidated. In the current study, we examined the role of IL-2 in IFN-γ production by CD8(+) immune T cells in their secondary responses using T. gondii-specific CD8(+) T cell hybridomas and splenic CD8(+) immune T cells from chronically infected mice. The majority (92%) of CD8(+) T cell hybridomas produced large amounts of IFN-γ only when a low amount (0.5 ng/ml) of exogenous IL-2 was provided in combination with T. gondii Ags. Inhibition of cell proliferation by mitomycin C did not affect the enhancing effect of IL-2 on the IFN-γ production, and significant increases in transcription factor T-bet expression were associated with the IL-2-mediated IFN-γ amplification. Splenic CD8(+) immune T cells produced similar low levels of IL-2 in the secondary response to T. gondii, and a blocking of IL-2 signaling by anti-IL-2Rα Ab or inhibitors of JAK1 and JAK3 significantly reduced IFN-γ production of the T cells. This IL-2-mediated upregulation of IFN-γ production was observed in mitomycin C-treated CD8(+) immune T cells, thus independent from their cell division. Therefore, endogenous IL-2 produced by CD8(+) immune T cells can play an important autocrine-enhancing role on their IFN-γ production in the secondary responses to T. gondii, suggesting an importance of induction of CD8(+) immune T cells with an appropriate IL-2 production for vaccine development.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23359502      PMCID: PMC3578122          DOI: 10.4049/jimmunol.1202256

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Cytokine production of CD8+ immune T cells but not of CD4+ T cells from Toxoplasma gondii-infected mice is polarized to a type 1 response following stimulation with tachyzoite-infected macrophages.

Authors:  Renee Miller; Xiangshu Wen; Bradley Dunford; Xisheng Wang; Yasuhiro Suzuki
Journal:  J Interferon Cytokine Res       Date:  2006-11       Impact factor: 2.607

2.  Strains of Toxoplasma gondii used for tachyzoite antigens to stimulate spleen cells of infected mice in vitro affect cytokine responses of the cells in the culture.

Authors:  Laurel Rodgers; Xisheng Wang; Xiangshu Wen; Bradley Dunford; Renee Miller; Yasuhiro Suzuki
Journal:  Parasitol Res       Date:  2005-07-07       Impact factor: 2.289

3.  Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T cells.

Authors:  Sonja Lütjen; Sabine Soltek; Simona Virna; Martina Deckert; Dirk Schlüter
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

4.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor.

Authors:  Nikhil S Joshi; Weiguo Cui; Anmol Chandele; Heung Kyu Lee; David R Urso; James Hagman; Laurent Gapin; Susan M Kaech
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

Review 5.  The T-box transcription factor T-bet in immunity and autoimmunity.

Authors:  Stanford L Peng
Journal:  Cell Mol Immunol       Date:  2006-04       Impact factor: 11.530

6.  Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria.

Authors:  Nathan W Schmidt; Rebecca L Podyminogin; Noah S Butler; Vladimir P Badovinac; Brad J Tucker; Keith S Bahjat; Peter Lauer; Arturo Reyes-Sandoval; Claire L Hutchings; Anne C Moore; Sarah C Gilbert; Adrian V Hill; Lyric C Bartholomay; John T Harty
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

7.  Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.

Authors:  Martin F Bachmann; Petra Wolint; Senta Walton; Katrin Schwarz; Annette Oxenius
Journal:  Eur J Immunol       Date:  2007-06       Impact factor: 5.532

8.  Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells.

Authors:  Matthew E Pipkin; Jilian A Sacks; Fernando Cruz-Guilloty; Mathias G Lichtenheld; Michael J Bevan; Anjana Rao
Journal:  Immunity       Date:  2010-01-21       Impact factor: 31.745

Review 9.  The biology of interleukin-2.

Authors:  Thomas R Malek
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

10.  Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

Authors:  Matthew A Williams; Aaron J Tyznik; Michael J Bevan
Journal:  Nature       Date:  2006-06-15       Impact factor: 49.962

View more
  20 in total

1.  Determination of a Key Antigen for Immunological Intervention To Target the Latent Stage of Toxoplasma gondii.

Authors:  Qila Sa; Eri Ochiai; Ashish Tiwari; Jeremi Mullins; Nilabh Shastri; Corinne Mercier; Marie-France Cesbron-Delauw; Yasuhiro Suzuki
Journal:  J Immunol       Date:  2017-04-26       Impact factor: 5.422

Review 2.  CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection.

Authors:  SuJin Hwang; Imtiaz A Khan
Journal:  Semin Immunopathol       Date:  2015-05-06       Impact factor: 9.623

3.  Configuration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity.

Authors:  Enping Hong; Ilana M Usiskin; Cristina Bergamaschi; Douglas J Hanlon; Richard L Edelson; Sune Justesen; George N Pavlakis; Richard A Flavell; Tarek M Fahmy
Journal:  J Biol Chem       Date:  2015-12-30       Impact factor: 5.157

4.  Hydroxyurea and Zileuton Differentially Modulate Cell Proliferation and Interleukin-2 Secretion by Murine Spleen Cells: Possible Implication on the Immune Function and Risk of Pain Crisis in Patients with Sickle Cell Disease.

Authors:  Solo Kuvibidila; Rajasekharan P Warrier; Johnson Haynes; Surendra B Baliga
Journal:  Ochsner J       Date:  2015

5.  Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist.

Authors:  Caleb R Glassman; Leon Su; Sonia S Majri-Morrison; Hauke Winkelmann; Fei Mo; Peng Li; Magdiel Pérez-Cruz; Peggy P Ho; Ievgen Koliesnik; Nadine Nagy; Tereza Hnizdilova; Lora K Picton; Marek Kovar; Paul Bollyky; Lawrence Steinman; Everett Meyer; Jacob Piehler; Warren J Leonard; K Christopher Garcia
Journal:  Elife       Date:  2021-05-18       Impact factor: 8.140

6.  Single cell tuning of Myc expression by antigen receptor signal strength and interleukin-2 in T lymphocytes.

Authors:  Gavin C Preston; Linda V Sinclair; Aneesa Kaskar; Jens L Hukelmann; Maria N Navarro; Isabel Ferrero; H Robson MacDonald; Victoria H Cowling; Doreen A Cantrell
Journal:  EMBO J       Date:  2015-07-01       Impact factor: 11.598

7.  Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice.

Authors:  Hai-Long Wang; Li-Min Wen; Yan-Jiang Pei; Fen Wang; Li-Tian Yin; Ji-Zhong Bai; Rui Guo; Chun-Fang Wang; Guo-Rong Yin
Journal:  Parasite       Date:  2016-03-16       Impact factor: 3.000

8.  Periostin Upregulates Wnt/β-Catenin Signaling to Promote the Osteogenesis of CTLA4-Modified Human Bone Marrow-Mesenchymal Stem Cells.

Authors:  Fei Zhang; Keyu Luo; Zhigang Rong; Zhengdong Wang; Fei Luo; Zehua Zhang; Dong Sun; Shiwu Dong; Jianzhong Xu; Fei Dai
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

9.  CD8+ T Cell Responses to Plasmodium and Intracellular Parasites.

Authors:  Nicolas Villarino; Nathan W Schmidt
Journal:  Curr Immunol Rev       Date:  2013-08

Review 10.  Applications and therapeutic actions of complementary and alternative medicine for women with genital infection.

Authors:  Chenfang Liu; Yuehui Zhang; Sai Kong; Ilene Tsui; Yang Yu; Fengjuan Han
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.